Aristides Capital’s LifeVantage LFVN Stock Holding History

Aristides Capital’s Portfolio LFVN Stock Details LFVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,300	Closed	-$75.8K	–	234
2025 Q4	$75.8K	Buy	+12,300	New	+$91.1K	0.01%	260

Other funds holding LFVN

Capital Management Glen Allen, Virginia $585M AUM 5.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Aristides Capital's LFVN Position: Q1 2026 in Review

Aristides Capital sold out of LifeVantage (LFVN) in Q1 2026, closing a stake of 12,300 shares — an estimated $75.8K sold.

Aristides Capital first reported a position in LFVN in Q4 2025 and held it in 1 quarter. The position peaked at $75.8K in Q4 2025. 104 funds tracked by Wall St. Rank hold LFVN as of Q1 2026.

Aristides Capital reported no remaining LifeVantage position as of Q1 2026 after selling out during the quarter.
Aristides Capital sold 12,300 LifeVantage shares in Q1 2026, an estimated $75.8K.
Aristides Capital first reported a position in LifeVantage in Q4 2025 and held it in 1 quarter.
Aristides Capital's LifeVantage position peaked at $75.8K in Q4 2025.
104 funds tracked by Wall St. Rank held LifeVantage as of Q1 2026.

Based on Aristides Capital's 13F filing for Q1 2026, filed 14 May 2026.